Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jun 15;191(12):1422-31.
doi: 10.1164/rccm.201411-1988OC.

Natural T Cell-mediated Protection against Seasonal and Pandemic Influenza. Results of the Flu Watch Cohort Study

Andrew C Hayward  1 , Lili Wang  2 , Nilu Goonetilleke  2   3 , Ellen B Fragaszy  1   4 , Alison Bermingham  5 , Andrew Copas  6 , Oliver Dukes  1 , Elizabeth R C Millett  6   4 , Irwin Nazareth  7 , Jonathan S Nguyen-Van-Tam  8 , John M Watson  9 , Maria Zambon  5 ; Flu Watch Group; Anne M Johnson  6 , Andrew J McMichael  2
Collaborators, Affiliations

Natural T Cell-mediated Protection against Seasonal and Pandemic Influenza. Results of the Flu Watch Cohort Study

Andrew C Hayward et al. Am J Respir Crit Care Med. .

Abstract

Rationale: A high proportion of influenza infections are asymptomatic. Animal and human challenge studies and observational studies suggest T cells protect against disease among those infected, but the impact of T-cell immunity at the population level is unknown.

Objectives: To investigate whether naturally preexisting T-cell responses targeting highly conserved internal influenza proteins could provide cross-protective immunity against pandemic and seasonal influenza.

Methods: We quantified influenza A(H3N2) virus-specific T cells in a population cohort during seasonal and pandemic periods between 2006 and 2010. Follow-up included paired serology, symptom reporting, and polymerase chain reaction (PCR) investigation of symptomatic cases.

Measurements and main results: A total of 1,414 unvaccinated individuals had baseline T-cell measurements (1,703 participant observation sets). T-cell responses to A(H3N2) virus nucleoprotein (NP) dominated and strongly cross-reacted with A(H1N1)pdm09 NP (P < 0.001) in participants lacking antibody to A(H1N1)pdm09. Comparison of paired preseason and post-season sera (1,431 sets) showed 205 (14%) had evidence of infection based on fourfold influenza antibody titer rises. The presence of NP-specific T cells before exposure to virus correlated with less symptomatic, PCR-positive influenza A (overall adjusted odds ratio, 0.27; 95% confidence interval, 0.11-0.68; P = 0.005, during pandemic [P = 0.047] and seasonal [P = 0.049] periods). Protection was independent of baseline antibodies. Influenza-specific T-cell responses were detected in 43%, indicating a substantial population impact.

Conclusions: Naturally occurring cross-protective T-cell immunity protects against symptomatic PCR-confirmed disease in those with evidence of infection and helps to explain why many infections do not cause symptoms. Vaccines stimulating T cells may provide important cross-protective immunity.

Keywords: T lymphocytes; cellular immunity; cohort studies.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Preexisting ex vivo influenza-specific T-cell response. The preseason ex vivo frequency of influenza (H3N2)-specific T-cell responses from 1,703 baseline measurements from 1,414 Flu Watch participants were quantified by IFN-γ enzyme-linked immunospot assay. Some participants contributed to more than one season, but no participant had more than one baseline measurement per season. (A) Each column represents a different baseline sample. The height of each column represents the ex vivo frequency (spot-forming units per million [SFU/M] peripheral blood mononuclear cells [PBMC]) of H3N2-specific T-cell response; each color represents the T-cell responses targeted at each H3N2 viral antigen as indicated below the bar chart. (B) For the same samples as in A, the ex vivo nucleoprotein (NP)-specific T-cell responses (y-axis) are plotted on a log10 scale and ordered on the x-axis by the strength of the response. (C) For the total ex vivo T-cell responses in the whole study, the proportional contribution of each H3N2 viral antigen specificity is shown, indicating for instance that NP-specific T cells constitute 25% of the whole response. (D) Percentage of Flu Watch baseline samples that had ex vivo detectable memory T-cell responses. For each influenza protein response, we subtracted the negative control well result from the test well result and accepted values of greater than or equal to 20 SFU/M PBMC as reactors if the original result was also significantly higher than that of the negative control wells (P < 0.05 based on the negative binomial distribution). HA = hemagglutinin; M = matrix; NA = neuraminidase; NS = nonstructural; PA = polymerase A; PB1 = polymerase B1; PB2 = polymerase B2.
Figure 2.
Figure 2.
Preexisting influenza nucleoprotein (NP)- and matrix (M)-specific T cells cross-react to pandemic H1N1 2009 (H1N1pdm2009). The frequencies of T-cell responses to pandemic H1N1 2009 NP and M peptides were quantified ex vivo from Flu Watch participants (n = 222) who had no detectable antibody against pandemic H1N1 2009 HA at baseline. Each dot represents one Flu Watch participant. (A) The log10-transformed ex vivo frequency of H3N2 NP-specific T-cell response is shown on the x-axis, and the log10-transformed ex vivo frequency of the T cells targeted at pandemic H1N1 2009 NP is shown on the y-axis. The NP T-cell responses were quantified by IFN-γ enzyme-linked immunospot assay, and backgrounds were subtracted in the data presented in this figure. Linear regression line coefficient = 0.79 (95% confidence interval, 0.77–0.81); P < 0.001. (B) The equivalent for M responses. Linear regression line coefficient = 0.68 (95% confidence interval, 0.66–0.70); P < 0.0001. PBMC = peripheral blood mononuclear cells; SFU/M = spot-forming units per million.
Figure 3.
Figure 3.
CD4 and CD8 phenotype of preexisting influenza-specific T cells. The preseason influenza (H3N2)-specific T-cell responses from 174 randomly selected Flu Watch participants were expanded by culture with peptide and IL-2, and the frequency of CD4+ and CD8+ influenza-specific T cells were measured by intracellular IFN-γ staining (y-axis). The height of each column indicates the percentage of all influenza-specific T cells (CD3+ IFN-γ+) responding to H3N2 virus peptides representing each protein. The gray and red indicate the relative CD4+ and CD8+ T-cell responses. HA = hemagglutinin; M = matrix; NA = neuraminidase; NP = nucleoprotein; NS = nonstructural; PA = polymerase A; PB1 = polymerase B1; PB2 = polymerase B2.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Hayward AC, Fragaszy EB, Bermingham A, Wang L, Copas A, Edmunds JW, Ferguson N, Goonetilleke N, Harvey G, Kovar J, et al. Comparative community burden and severity of seasonal and pandemic influenza: results of the Flu Watch cohort study. Lancet Respir Med. 2014;2:445–454. - PMC - PubMed
    1. Carrat F, Vergu E, Ferguson NM, Lemaitre M, Cauchemez S, Leach S, Valleron AJ. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol. 2008;167:775–785. - PubMed
    1. Wang TE, Lin CY, King CC, Lee WC. Estimating pathogen-specific asymptomatic ratios. Epidemiology. 2010;21:726–728. - PubMed
    1. Hoyle L, Fairbrother RW. Isolation of the influenza virus and the relation of antibodies to infection and immunity: the Manchester influenza epidemic of 1937. BMJ. 1937;1:655–657. - PMC - PubMed
    1. Noble GR. Epidemiological and clinical aspects of influenza. In: Beare AS, editor. Basic and applied influenza research. Boca Raton, FL: CRC Press; 1982. pp. 11–50.

MeSH terms